You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

PATANOL^® solution IMPORTANT SAFETY INFORMATION: PATANOL^® solution is indicated for the treatment of the signs and symptoms of allergic conjunctivitis. PATANOL^® solution is contraindicated in persons with a known hypersensitivity to olopatadine hydrochloride or any components of this product. Safety and effectiveness in pediatric patients below the age of 3 has not been established. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least ten minutes after instilling PATANOL^® solution before they insert their contact lenses. Headaches have been reported at an incidence of 7%. The following adverse experiences have been reported in less than 5% of patients: asthenia, blurred vision, burning or stinging, cold syndrome, dry eye, foreign body sensation, hyperemia, hypersensitivity, keratitis, lid edema, nausea, pharyngitis, pruritus, rhinitis, sinusitis, and taste perversion. The recommended dose is one drop in each affected eye two times per day at an interval of 6 to 8 hours. Click here for more information.

PATADAY^™ solution IMPORTANT SAFETY INFORMATION: PATADAY^™ solution is indicated for the treatment of ocular itching associated with allergic conjunctivitis. PATADAY^™ solution is contraindicated in patients with a hypersensitivity to any components of this product. Patients who wear soft contact lenses and whose eyes are not red should be instructed to wait at least ten minutes after instilling PATADAY^™ solution before they insert their contact lenses. Safety and effectiveness in pediatric patients below the age of 3 has not been established. The most common adverse reactions to PATADAY^™ solution were cold syndrome and pharyngitis reported at an incidence of approximately 10%. Other adverse events included eye pain, blurred vision, sinusitis and headache occurring in 5% or less of the patients. The recommended dose is one drop in each affected eye once-a-day.
Click here for more information.